Skip to main content
Smart Investors Daily
SP

NASDAQ · SPKB

Silver Spike Acquisition Corp II

Financial Services · Shell Companies

$10.22

Down-$0.02 (-0.20%)

Updated Aug 16, 2026, 8:53 PM

SID Score

Composite research score

Smart Money

Institutional and insider signal

Market cap
367.28M
P/E ratio
263.01
Dividend yield
0.00%
52-week range
— – —
Volume
4.4K
Avg. volume
132.76K

Price performance

SPKB price history

1M range · 0 trading sessions · Daily adjusted prices

SPKB does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest SPKB news

The latest Smart Investors Daily articles mentioning SPKB.

SPKB research

Overview

Company profile and research snapshot.

Company profile

Silver Spike Acquisition Corp II does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, and similar business combination with one or more businesses or entities in cannabis industry. The company was incorporated in 2020 and is based in New York, New York.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

GlobeNewswire Inc. · Mar 14, 2023

Silver Spike Acquisition Corp II Announces Redemption of Class A Ordinary Shares

NEW YORK, March 13, 2023 (GLOBE NEWSWIRE) -- Silver Spike Acquisition Corp II (the “Company”) today announced that it will redeem all of its outstanding Class A ordinary shares (the “Class A Ordinary Shares”), effective as of March 27, 2023, because the Company will not consummate an initial business combination within the time period required by its amended and restated memorandum and articles of association (the “Articles”).

Benzinga · Jan 24, 2022

Psyched: Eleusis To Go Public Via Merger, New Psychedelics Bills In Utah, Virginia, Kansas And Missouri

Psychedelics Legalization Gains Momentum Around The Country: Bills Introduced In Utah, Virginia, Kansas And Missouri A wave of psychedelics legislation continues to sweep across the country. In Virginia, two very similar proposals were introduced simultaneously in the House and Senate by Del. Dawn Adams and Sen. Ghazala Hashmi. The bills would amend the state’s drug statute by making possession of psilocybin and psilocin by adults 21 and older a civil penalty subject to a $100 fine, from what currently constitutes a Class 5 felony. The Senate bill also includes peyote and ibogaine in its language. In Utah, Rep. Brady Brammer introduced a bill intended to set up a task force to study and make recommendations on the therapeutic potential of psychedelic drugs and possible regulations around their use. In Kansas, a bill was introduced to legalize low-level possession and cultivation of psilocybin mushrooms. If approved, the “Legalized Homegrown Psilocybin Mushroom Act of 2022,” would remove criminal penalties for possessing up to 50 grams of psilocybin or psilocin or cultivating psilocybin mushrooms. The bill would amend a state statute to make it “not be a violation” of state law to cultivate psilocin or psilocybin. Last week, a Republican lawmaker in Missouri filed a bill to give residents with serious illnesses legal access to a range of psychedelic drugs like psilocybin, ibogaine and LSD through an expanded version of the state’s existing right-to-try law. Eleusis To Go Public Via Merger With Silver Spike Acquisition Creating $450M Company British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (NASDAQ: SPKB), a special purpose acquisition company sponsored by an affiliate of Silver Spike Capital. The two companies confirmed Thursday they have signed a definitive business combination agreement expected to make Eleusis a public company. Upon the close of the transaction, the combined company will ...

Benzinga · Jan 20, 2022

Psychedelics Firm Eleusis Goes Public Via Merger With Silver Spike Acquisition Creating $450M Company

British psychedelics company Eleusis will go public via a merger with Silver Spike Acquisition Corp. II (“SPKB”) (NASDAQ: SPKB), a special purpose acquisition company sponsored by an affiliate of Silver Spike Capital. The two companies confirmed Thursday they have signed a definitive business combination agreement expected to make Eleusis a public company. Upon the close of the transaction, the combined company will be operated through Eleusis Inc., a new holding company, and will apply to have its common stock listed on Nasdaq under the symbol “ELEU.” “This is an ideal moment for Eleusis to go public with a partner like Silver Spike,” Shlomi Raz, CEO and founder of Eleusis stated. “We are thrilled to work with the Silver Spike team, whose extensive financial and industry experience complement our expertise. We believe access to public capital markets will accelerate our efforts to transform psychedelics into modern medicines, and ultimately offers the potential to improve millions of patients’ lives while creating long-term value for our shareholders.” The Merger Highlights The transaction implies a ...

Benzinga · Jan 14, 2022

Why Does CNBC's Tim Seymour Think It's Wise To Invest In Cannabis?

With a spike in share prices within the cannabis sector in the week following the Republicans' release of their marijuana legalization proposal in November, it's hard not to think of federal regulation as an important catalyst. However, during the week following Rep. Nancy Mace (R-SC) officially laying out her cannabis legalization plan, pot stocks took a massive beating. Tim Seymour, director and founder of The Amplify Seymour Cannabis ETF CNBS (ARCA: CNBS), said that investors should not be investing in cannabis "necessarily based upon an expectation of some federal catalyst." Seymour was a guest on Benzinga's PreMarket Prep live trading talk show on Friday. Nevertheless, ...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.